MARIA
GARCIA GARROTE
Investigadora contratada posdoctoral
Publicaciones (11) Publicaciones de MARIA GARCIA GARROTE
2023
-
Combined cell-based therapy strategies for the treatment of Parkinson's disease: Focus on mesenchymal stromal cells
Neural Regeneration Research, Vol. 18, Núm. 3, pp. 478-484
2022
-
Microglial angiotensin type 2 receptors mediate sex-specific expression of inflammatory cytokines independently of circulating estrogen
GLIA, Vol. 70, Núm. 12, pp. 2348-2360
2021
-
Dopamine regulates adult neurogenesis in the ventricular-subventricular zone via dopamine D3 angiotensin type 2 receptor interactions
Stem Cells, Vol. 39, Núm. 12, pp. 1778-1794
-
Dose-dependent effect of mesenchymal stromal cells co-grafted with dopaminergic neurons in a Parkinson's disease rat model
Journal of Cellular and Molecular Medicine, Vol. 25, Núm. 20, pp. 9884-9889
-
Nadph-oxidase, rho-kinase and autophagy mediate the (Pro)renin-induced pro-inflammatory microglial response and enhancement of dopaminergic neuron death
Antioxidants, Vol. 10, Núm. 9
-
Nrf2 activation and downstream effects: Focus on parkinson’s disease and brain angiotensin
Antioxidants, Vol. 10, Núm. 11
2020
-
Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra
Brain, Behavior, and Immunity, Vol. 87, pp. 256-271
2019
2018
-
Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells
Free Radical Biology and Medicine, Vol. 129, pp. 394-406
-
Data on the effect of Angiotensin II and 6-hydroxydopamine on reactive oxygen species production, antioxidant gene expression and viability of different neuronal cell lines
Data in Brief
-
Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons
Molecular Neurobiology, Vol. 55, Núm. 6, pp. 4763-4776